Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aerpio Announces Completion of Patient Dosing in AKB-9778 Study

americanpharmaceuticalreviewJanuary 21, 2019

Tag: Aerpio , AKB-9778 Study , NPDR , ocular diseases

PharmaSources Customer Service